Clinical Trial Update: Pilot Trial of Resistant Starch in Stage I-III Colorectal Cancer Survivors [Phase 2]

View source ↗

Summary

A Phase 2 pilot trial evaluated resistant starch in survivors of stage I-III colorectal cancer and is reported as terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Cancer
• Colorectal Cancer
• Rectal Cancer

Drugs mentioned

• Resistant starch (Resistant starch)

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: Colon Cancer, Rectal Cancer | Phase 2 | Status: TERMINATED | Results posted: 2021-12-14